Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1657 | 2 | FEBRILE NEUTROPENIA//METASTATIC BREAST CANCER//NEUTROPENIA | 7171 |
1761 | 1 | FEBRILE NEUTROPENIA//NEUTROPENIA//NEUTROPENIC FEVER | 2530 |
2226 | 1 | METASTATIC BREAST CANCER//VINORELBINE//CAPECITABINE | 2351 |
11908 | 1 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM | 973 |
13996 | 1 | HIGH DOSE CHEMOTHERAPY//THIOTEPA//HIGH RISK BREAST CANCER | 830 |
29865 | 1 | BODY SURFACE AREA//DRUG WASTE//DOSE BANDING | 195 |
34975 | 1 | CONSERVATION KNOWLEDGE//INSTITUTIONAL RESEARCH//ACTIVIST EVALUATION | 118 |
35389 | 1 | DNA COUPLED COLUMN//GOAL OF TREATMENT//TEMPERATURE GRADIENT ELUTION | 112 |
38428 | 1 | BUHKYO KU//CASE MIX COST ACCOUNTING//CONTINUOUS HEALTH CARE | 62 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | authKW | 1434550 | 7% | 63% | 515 |
2 | METASTATIC BREAST CANCER | authKW | 771907 | 8% | 33% | 540 |
3 | NEUTROPENIA | authKW | 580291 | 8% | 22% | 592 |
4 | PEGFILGRASTIM | authKW | 569305 | 2% | 81% | 161 |
5 | FILGRASTIM | authKW | 205359 | 2% | 37% | 125 |
6 | VINORELBINE | authKW | 189445 | 3% | 21% | 203 |
7 | ADVANCED BREAST CANCER | authKW | 144936 | 2% | 27% | 123 |
8 | DOCETAXEL | authKW | 134090 | 5% | 9% | 336 |
9 | CAPECITABINE | authKW | 132859 | 3% | 14% | 218 |
10 | CHEMOTHERAPY INDUCED NEUTROPENIA | authKW | 118596 | 1% | 75% | 36 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 94596 | 59% | 1% | 4240 |
2 | Infectious Diseases | 8774 | 11% | 0% | 791 |
3 | Hematology | 8448 | 11% | 0% | 794 |
4 | Pharmacology & Pharmacy | 2576 | 13% | 0% | 957 |
5 | Health Care Sciences & Services | 2056 | 4% | 0% | 292 |
6 | Medicine, General & Internal | 2028 | 9% | 0% | 667 |
7 | Transplantation | 1547 | 3% | 0% | 245 |
8 | Pediatrics | 1056 | 5% | 0% | 371 |
9 | Microbiology | 1048 | 6% | 0% | 464 |
10 | Rehabilitation | 969 | 3% | 0% | 202 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MED ONCOL | 33635 | 9% | 1% | 624 |
2 | NO ALBERTA BREAST CANC PROGRAM | 30752 | 0% | 100% | 7 |
3 | IMMUNOCOMPROMISED HOST DIS UNIT | 17572 | 0% | 100% | 4 |
4 | CANC THER Y DEV PROGRAM | 14056 | 0% | 80% | 4 |
5 | BERLIN BREAST CANC GRP | 13179 | 0% | 100% | 3 |
6 | HLTH SERV OUTCOMES PROGRAM | 13179 | 0% | 100% | 3 |
7 | BREAST CANC MED SERV | 12694 | 0% | 13% | 22 |
8 | BREAST MED ONCOL | 12537 | 1% | 4% | 65 |
9 | BREAST ONCOL GRP | 10038 | 0% | 57% | 4 |
10 | MEDDON MONTI ONCOL | 10038 | 0% | 57% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SEMINARS IN ONCOLOGY | 51142 | 3% | 5% | 247 |
2 | JOURNAL OF CLINICAL ONCOLOGY | 33260 | 5% | 2% | 355 |
3 | SUPPORTIVE CARE IN CANCER | 33095 | 3% | 4% | 185 |
4 | ANNALS OF ONCOLOGY | 30335 | 3% | 3% | 243 |
5 | BREAST CANCER RESEARCH AND TREATMENT | 13932 | 2% | 2% | 155 |
6 | BONE MARROW TRANSPLANTATION | 13518 | 2% | 2% | 167 |
7 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 13071 | 2% | 3% | 111 |
8 | EUROPEAN JOURNAL OF CANCER | 11917 | 2% | 2% | 168 |
9 | ONCOLOGY | 11507 | 1% | 3% | 103 |
10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 10470 | 2% | 2% | 135 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | 1434550 | 7% | 63% | 515 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
2 | METASTATIC BREAST CANCER | 771907 | 8% | 33% | 540 | Search METASTATIC+BREAST+CANCER | Search METASTATIC+BREAST+CANCER |
3 | NEUTROPENIA | 580291 | 8% | 22% | 592 | Search NEUTROPENIA | Search NEUTROPENIA |
4 | PEGFILGRASTIM | 569305 | 2% | 81% | 161 | Search PEGFILGRASTIM | Search PEGFILGRASTIM |
5 | FILGRASTIM | 205359 | 2% | 37% | 125 | Search FILGRASTIM | Search FILGRASTIM |
6 | VINORELBINE | 189445 | 3% | 21% | 203 | Search VINORELBINE | Search VINORELBINE |
7 | ADVANCED BREAST CANCER | 144936 | 2% | 27% | 123 | Search ADVANCED+BREAST+CANCER | Search ADVANCED+BREAST+CANCER |
8 | DOCETAXEL | 134090 | 5% | 9% | 336 | Search DOCETAXEL | Search DOCETAXEL |
9 | CAPECITABINE | 132859 | 3% | 14% | 218 | Search CAPECITABINE | Search CAPECITABINE |
10 | CHEMOTHERAPY INDUCED NEUTROPENIA | 118596 | 1% | 75% | 36 | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |